|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.82 EUR | -0.51% |
|
-5.56% | +24.57% |
| Jun. 17 | FMC under pressure – medium-term revenue target missed | DP |
| Jun. 10 | Hospitals demand billions in emergency aid | DP |
Business description: Fresenius SE & Co. KGaA
- hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.;
- perfusion and clinical nutrition (39.1%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. ;
- other (1.7%).
Number of employees: 175,202
Sales by Activity: Fresenius SE & Co. KGaA
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Fresenius Helios | 9.82B | 10.89B | 11.72B | 12.32B | 12.74B |
Fresenius Kabi | 6.98B | 7.19B | 7.85B | 8.01B | 8.41B |
Corporate / Other | -444M | -480M | -483M | -386M | 680M |
Fresenius Vamed | 2.07B | 2.3B | 2.36B | 2.36B | - |
Fresenius Medical Care | 17.86B | 17.62B | 19.4B | - | - |
Geographical breakdown of sales: Fresenius SE & Co. KGaA
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Europe | 15.81B | 16.89B | 17.88B | 16.15B | 15.66B |
North America | 14.8B | 14.36B | 16.11B | 2.74B | 2.7B |
Asia-Pacific | 3.7B | 3.94B | 4.14B | 1.64B | 1.6B |
Latin America | 1.57B | 1.83B | 2.18B | 1.42B | 1.4B |
Africa | 392M | 501M | 534M | 356M | 156M |
Executive Committee: Fresenius SE & Co. KGaA
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 56 | 2022-09-30 |
Sara Hennicken
DFI | Director of Finance/CFO | 45 | 2022-08-31 |
Michael Moser
CMP | Compliance Officer | 48 | - |
| Corporate Secretary | - | - | |
Markus Georgi
IRC | Investor Relations Contact | - | 2014-12-31 |
Composition of the Board of Directors: Fresenius SE & Co. KGaA
| Director | Title | Age | Since |
|---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 70 | 2015-05-19 |
| Director/Board Member | 64 | 2016-05-12 | |
| Director/Board Member | 51 | 2007-12-31 | |
Bernd Behlert
BRD | Director/Board Member | 66 | 2018-08-31 |
Wolfgang Kirsch
CHM | Chairman | 70 | 2021-05-20 |
Grit Genster
BRD | Director/Board Member | 52 | 2020-04-30 |
Susanne Zeidler
BRD | Director/Board Member | 64 | 2022-02-08 |
Christoph Zindel
BRD | Director/Board Member | 63 | 2022-05-12 |
Holdings: Fresenius SE & Co. KGaA
| Name | Equities | % | Valuation |
|---|---|---|---|
FRESENIUS MEDICAL CARE AG 28.55% | 83,780,382 | 28.55% | 4,757,486,586 $ |
Company details: Fresenius SE & Co. KGaA
Group companies: Fresenius SE & Co. KGaA
| Name | Category and Sector |
|---|---|
Fresenius Kabi Hungary Vegy-, Gyógyszeripari és Kereskedelmi
 Fresenius Kabi Hungary Vegy-, Gyógyszeripari és Kereskedelmi Pharmaceuticals: MajorHealth Technology Fresenius Kabi Hungary Vegy-, Gyógyszeripari és Kereskedelmi Kft. engages in the trade of medical products and devices. It offers intravenous solutions, antibiotics, preparations, antibacterial and antifungal drugs, chemotherapeutic agents, clinical nutrition, transfusion technology, and infusion therapy equipment,. The company was founded on December 15, 1991 and is headquartered in Budapest, Hungary. |
Pharmaceuticals: Major
|
Fresenius Medical Care India Pvt Ltd.
 Fresenius Medical Care India Pvt Ltd. Medical SpecialtiesHealth Technology Part of Fresenius Medical Care AG, Fresenius Medical Care India Pvt Ltd. is a company that specializes in high quality water technology dialysis products and services tailored to the needs of their patients. The company is based in New Delhi, India. The Indian company offers innovative products, therapies, and services for chronic and acute kidney dialysis and therapeutic apheresis. |
Medical Specialties
|
Medical/Nursing Services
| |
Fresenius-Kawasumi Co., Ltd. | |
Clinico Medical Sp zoo
 Clinico Medical Sp zoo Pharmaceuticals: OtherHealth Technology Part of Else Kröner-Fresenius-Stiftung, Clinico Medical Sp zoo is a Polish company that has no clear description of its business. The company is based in Blonie, Poland. The only information provided is that the domain name is for sale on a Polish website called AfterMarket.pl. |
Pharmaceuticals: Other
|
Other Healthcare Facilities & Services
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.14% | -5.83% | +46.12% | +42.57% | 27.27B | ||
| +1.18% | +2.52% | +10.63% | +117.71% | 90.66B | ||
| -0.37% | +1.70% | +9.56% | -24.61% | 84.55B | ||
| +0.67% | -3.82% | -19.40% | +22.12% | 22.39B | ||
| +0.75% | +0.55% | +26.58% | +15.55% | 21.88B | ||
| +0.46% | +1.58% | +30.94% | +37.61% | 20.07B | ||
| -0.87% | -7.26% | +27.55% | -7.15% | 15.76B | ||
| +0.07% | +3.82% | +21.87% | +216.49% | 15.57B | ||
| -0.62% | -0.14% | +34.62% | +17.02% | 14.18B | ||
| -2.24% | -3.72% | +28.45% | +219.52% | 13.3B | ||
| Average | -0.20% | -0.22% | +21.69% | +65.68% | 32.56B | |
| Weighted average by Cap. | +0.11% | +1.13% | +16.71% | +54.54% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FRE Stock
- Company Fresenius SE & Co. KGaA
Select your edition
All financial news and data tailored to specific country editions
